|
ATR 1072 Clinical Trials
1 actively recruiting trial across 1 location
Pipeline
Phase 1/2: 1
Top Sponsors
- Atrium Therapeutics1
Indications
- Wolff-Parkinson-White Syndrome1
- Cardiac Glycogenosis1
- Hypertrophic1
- Heart Disease1
- Cardiomyopathy1
Kansas City, Missouri1 trial
ATR 1072 in Participants With PRKAG2 Syndrome
St Luke's Mid American Heart Institute
Phase 1/2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.